Neurosteer
Neurosteer provides the first ever miniature, easy-to-use and continuous neurological monitor. While improving medical intervention, this disruptive technology also provides neurological biomarkers. This helps pharmaceutical companies introduce new neurological and psychiatric drugs to the market, and streamline drug development and discovery. It enables better and less expensive patient screening and the continuous monitoring of patients throughout the study, addressing various compliance issues. It can accelerate "research-to-cure" time and improve patient condition characterization, leading to more personalized medicine, which will improve study accuracy and accelerate regulatory approval.
About Neurosteer
Founded
2015Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$7MCategory
Industry
Medical DevicesLocation
City
New York CityState
New YorkCountry
United StatesNeurosteer
Find your buyer within Neurosteer